{
    "medicine_id": "9d61523d0077f40b6b0db601be0c388b93ff5a78",
    "platform_id": "DB11150",
    "metadata": {
        "name": "Anatrast 560 mg 1g Paste",
        "composition": "560 mg 1g Barium sulfate",
        "clinical_particulars": {
            "therapeutic_indications": "Barium sulfate is a radiographic contrast agent indicated for use in computed tomography CT of the abdomen to delineate the gastrointestinal GI tract in adult and pediatric patients FDA label",
            "contraindications": {
                "disease": "Acute Exposure Nausea vomiting diarrhea and abdominal cramping may occur FDA label Acute exposure to barium sulfate may irritate the eyes and respiratory tract Exposure to inhalation or other forms can affect the nervous system and lead to hypokalemia which can contribute to cardiovascular rhythm abnormality L1957 Hypersensitivity gastrointestinal transit delay obstruction aspiration pneumonitis and systemic embolization of barium sulfate are more serious complications of administration FDA label In addition fatalities have occurred due to aspiration pneumonitis barium sulfate impaction intestinal perforation with subsequent peritonitis and granuloma formation and vasovagal and syncopal episodes FDA label A32329 Chronic Exposure The lungs may be affected by repeated or prolonged exposure to dust particles resulting in baritosis a type of benign pneumoconiosis L1957 Inhalation of barium sulfate dust may lead to a benign pneumoconiosis baritosis with conspicuous radiographic characteristics but no signs of impairment of pulmonary function L1957 Intra abdominal leakage Intra abdominal leakage may occur during or after administration of barium sulfate FDA label Caution is advised in several patient conditions such as fistulas ulcer inflammatory bowel disease appendicitis diverticulitis severe stenosis or obstruction of the GI tract Patients should maintain adequate hydration for several days following a barium sulfate procedure to prevent obstruction or impaction caused by batholiths barium sulfate stones L1959 Caution is advised in patients with a history of food aspiration and in patients with diagnosed swallowing disorders FDA label A note on GI perforation Perforation of the colon after rectal administration of barium sulfate suspension has been reported due to the increased hydrostatic pressure of the instilled suspension trauma to the colon from an enema tip or forceful or deep insertion of a non flexible enema tip Perforation of the bowel has been followed by peritonitis adhesions granulomas and death L1958 This is a rare occurrence Injury to the rectal mucosa or anal canal due to the enema tip or retention balloon is likely the most common traumatic cause of perforation during treatment Inflation of a balloon within a stricture neoplasm inflamed rectum or stoma is hazardous and caution should be exerted A32328 Carcinogenicity and mutagenicity No animal studies have been performed to evaluate the carcinogenicity of barium sulfate or potential effects on reproduction FDA label Elective contrast radiography of the abdomen is not routintely recommended during pregnancy because of the risks to the fetus from radiation exposure L1958",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Barium sulfate increases the absorption of x rays as they are passed throughout the body delineating body structures in which barium sulfate is localized This allows for the clear visualization of normal organs defect in normal anatomy L1959",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}